Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenylate kinase 2 pseudogene is an intronless processed pseudogene of the adenylate kinase 2 gene sequence. While the functional AK2 gene encodes a mitochondrial enzyme involved in nucleotide homeostasis[1][4][7], the pseudogene copy is not normally transcribed or translated into functional protein and lacks demonstrated biological activity or disease association[2][5][6]. Pseudogenes such as this are generally considered non-functional relics of gene duplication or retrotransposition events, and are not therapeutic targets. Key clarifications: - The gene designated here (adenylate kinase 2 pseudogene / ENSG00000185839 / AK2B / AK2P1) is not the functional adenylate kinase 2 gene (AK2, ENSG00000004455), which is an enzyme essential for cellular energy metabolism[1][4][7]. - This pseudogene neither encodes a protein nor serves as a recognized drug target. - There are other related pseudogenes colloquially termed AK2P1, AK2P2, etc., but none are therapeutically relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylate kinase 2 pseudogene.